Selling a Med Spa Business in Winston-Salem, NC — 2026 Market Guide

Winston-Salem's med spa market is small, affluent, and sticky — three traits that strategic acquirers and PE-backed aesthetics platforms pay premiums for. Med spas here are trading at 4.5x-8.0x EBITDA in 2026, with the Wake Forest Baptist Medical Center catchment driving steady injectable demand from a high-income demographic that doesn't churn the way urban patients do.

At a Glance — Winston-Salem Med Spa Market

  • Multiple Range: 4.5x-8.0x EBITDA
  • Population: ~250,000 (city); ~675,000 (Triad metro)
  • Anchor Employers: Wake Forest Baptist Medical Center, Hanesbrands, Reynolds American legacy, Wells Fargo regional
  • Active Buyers: LaserAway, Ideal Image, Skin Laundry, Advanced Dermatology, Skin Spectrum (Quad-C)
  • Sweet Spot: $1M-$8M revenue with 60%+ injectable mix
  • Timeline: 6-10 months from teaser to close

What Makes Winston-Salem's Med Spa Market Different?

Winston-Salem and the broader Triad punch above their weight on med spa economics for three reasons. First, demographic concentration — the patient pool is smaller than Charlotte or Raleigh, but income concentration around Wake Forest Baptist physician families, Hanesbrands and Reynolds American executive legacy, and Wells Fargo regional management produces consistent demand. Second, low patient mobility — Triad patients pick a med spa and stay; retention is materially higher than the state average. Third, less aggressive competition — fewer national chains have saturated the market, which means established local practices have defensible moats.

Buyers price these traits in. A Winston-Salem med spa with $1.5M revenue and proven retention will often valuate similarly to a $2M Charlotte med spa, because the Charlotte book has higher churn risk in the model. The Triad's stability is real money in the multiple.

Who's Buying Med Spas in Winston-Salem?

The named buyer universe in 2026 includes three distinct buyer types. National strategic platforms — LaserAway, Ideal Image, and Skin Laundry — target $2M+ revenue practices with established injectable programs. Regional dermatology-affiliated platforms like Advanced Dermatology & Cosmetic Surgery and Dermatology Associates buy med spas to add aesthetic services to existing dermatology footprints. PE-backed aesthetics platforms like Skin Spectrum (Quad-C) and several smaller roll-ups target tuck-in acquisitions in the $1M-$5M revenue range.

Local buyers also exist: physician investors looking to add a cash-pay business adjacent to their primary practice, and operator-owners moving from one practice to a second location. These buyers tend to pay slightly less but offer cleaner deal terms and faster closes.

What Do Med Spas Actually Sell For in Winston-Salem?

The 2026 multiples I see in this market are 6.5x-8.0x EBITDA for premium practices with $1.5M+ EBITDA, 60%+ injectable revenue, and clean physician oversight. Mid-tier practices with $500K-$1.5M EBITDA transact at 5.0x-6.5x. Smaller practices selling on SDE come in at 3.5x-5.0x. The premium tier requires three things: nurse injector retention (a high-performing injector who's likely to stay through a transaction is worth real money), compliance documentation (good-faith exams, supervising physician agreements, current state board compliance), and revenue mix that skews toward injectables rather than laser packages.

What Do Winston-Salem Med Spa Owners Need to Know Before Selling?

Three things will move your multiple before you ever talk to a buyer. First, get your physician oversight documented properly — North Carolina requires supervising physician agreements and good-faith exam protocols, and any gaps will be flagged in diligence and reduce price. Second, lock down injector retention with non-competes and stay bonuses; losing a top injector mid-deal kills value. Third, clean up your patient revenue tracking — buyers want to see retention curves, average ticket trends, and injectable-versus-laser splits, and if your software doesn't report this, fix it 12 months out. Plan on 6-10 months from teaser to close, and budget 12-18 months of preparation if physician oversight or compliance is messy.

I sold a Triad-area med spa last year — $2.1M revenue, $740K EBITDA, three injectors including a long-tenured nurse practitioner, clean Wake Forest physician oversight. We ran a quiet process with four strategic buyers and two PE platforms. Closed at 7.4x EBITDA. The Wake Forest demographic and the injector tenure carried that deal — buyers underwrote both as defensible moats. Without those two factors, same revenue would have transacted at 5.5x-6.0x. — John M. Salony

For more on Winston-Salem business sales across industries, see our Winston-Salem business sales hub, and for industry-specific buyer dynamics and current multiples, see our med spa industry hub.


Find Out What Your Business Is Worth in Winston-Salem

Get a free valuation estimate based on your revenue mix, injector retention, and EBITDA. Then schedule a confidential conversation about local buyer interest in your specific practice.

Schedule a Confidential Consultation

Frequently Asked Questions

What makes Winston-Salem's med spa market different from other NC cities?
Winston-Salem's med spa economics differ from Charlotte and Raleigh in three meaningful ways. First, the patient pool is smaller but more concentrated by income — Wake Forest Baptist Medical Center physician families, legacy Hanesbrands and Reynolds American executives, and Wells Fargo regional management produce stable cash-pay demand. Second, patient retention runs materially higher than the state average because Triad residents change providers less frequently than urban patients. Third, national chain saturation is lower in Winston-Salem than in Charlotte or Raleigh, which protects established local practices from competitive pressure. The combined effect: a $1.5M revenue Winston-Salem med spa often values similarly to a $2M Charlotte practice, because buyers price in the lower churn risk and demographic stability of the Triad market.
Who is buying med spas in Winston-Salem in 2026?
Three buyer types are active in Winston-Salem's med spa market in 2026. National strategic platforms — LaserAway, Ideal Image, and Skin Laundry — target practices doing $2M+ revenue with established injectable programs. Regional dermatology-affiliated platforms like Advanced Dermatology & Cosmetic Surgery and Dermatology Associates acquire med spas to add aesthetic services adjacent to existing dermatology footprints. PE-backed aesthetics platforms like Skin Spectrum (backed by Quad-C) target tuck-in acquisitions in the $1M-$5M revenue range. Local buyers — physician investors and operator-owners adding a second location — are also active and tend to offer cleaner deal terms but slightly lower multiples. The right buyer for your practice depends on your size, injectable mix, and timeline.
What do med spas actually sell for in Winston-Salem?
Winston-Salem med spa multiples in 2026 range from 4.5x to 8.0x EBITDA. Premium practices with $1.5M+ EBITDA, 60%+ injectable revenue (Botox, dermal fillers), and clean physician oversight transact at 6.5x-8.0x. Mid-tier practices with $500K-$1.5M EBITDA come in at 5.0x-6.5x. Smaller practices selling on SDE land at 3.5x-5.0x. Premium-tier valuations require nurse injector retention (proven, tenured injectors with stay incentives), compliance documentation (good-faith exam protocols, supervising physician agreements, current NC medical board compliance), and revenue mix weighted toward recurring injectables rather than laser packages. Practices missing any of these get docked 1.0x-1.5x EBITDA on the multiple.
What do Winston-Salem med spa owners need to know before selling?
Three preparation items will move your multiple before you talk to any buyer. First, document your physician oversight properly — North Carolina requires supervising physician agreements and good-faith exam protocols, and any gaps will surface in diligence and reduce the price. Second, lock down your injectors with non-competes and retention bonuses. Losing a top nurse injector mid-deal kills value because buyers underwrite the practice based on retained provider relationships. Third, clean up your patient revenue tracking — buyers will request retention curves, average ticket trends, and injectable-versus-laser revenue splits, and if your practice management software doesn't produce these reports, fix that 12 months ahead of going to market. Plan on 6-10 months from teaser to close, and budget 12-18 months of preparation if physician oversight or compliance documentation is messy.